+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Veterinary CRO and CDMO Market Size, Share & Trends Analysis Report by Animal (Companion Animals, Livestock Animals), Service (Discovery, Development), Application (Medicine, Medical Devices), and Region with Growth Forecasts, 2025-2030

  • PDF Icon

    Report

  • 100 Pages
  • May 2025
  • Region: Global
  • Grand View Research
  • ID: 6098185
The Veterinary CRO and CDMO Market was valued at USD 6.79 billion in 2024, and is projected to reach USD 11.42 billion by 2030, rising at a CAGR of 9.20%. Increasing expenditure on animal healthcare, growing inclination toward outsourcing processes such as research and development, and rising demand for effective animal health solutions worldwide are expected to drive market growth.

Significant investments in developing safe and efficient vaccines to prevent life-threatening diseases in livestock animals, growth in demand for novel medicines designed for companion animals, and an increase in pet ownership influence this market. In addition, the technical competence offered by CROs, advanced equipment capabilities of CDMOs, improved supply chain management, and easy distribution contribute to growth.

Rising collaborations among animal health companies and CROs or CDMOs for various applications, including clinical trials, research, discovery, and development, are likely to develop lucrative opportunities. Noteworthy investments by key market participants in portfolio enhancement, capacity expansion, and improved processes are projected to aid growth over the forecast period.

Veterinary CRO And CDMO Market Report Highlights

  • Livestock animals segment dominated the global market with more than 55% of revenue share in 2024 owing to growing concerns regarding the safety of meat and other byproducts associated with livestock animals, frequent outbreaks of novel diseases, and increasing demand for effective vaccines
  • The companion animals segment is expected to experience the fastest growth due to the significant increase in the adoption of various animal health products, such as medicine and devices specifically designed for pets
  • The development segment held the largest revenue share of the market in 2024, owing to the rising focus of multiple animal health companies on developing innovative products related to animal health and nutrition.
  • The discovery segment is expected to experience the fastest growth from 2025 to 2030, owing to increasing investment in research activities related to animal health products
  • In terms of application segment, medicine segment accounted for the highest market revenue share in 2024
  • North America dominated the global industry in 2024, owing to its strong pharmaceutical and biotechnology industry, presence of multiple CROs and CDMOs, and growing expenditures on animal health

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

Why Should You Buy This Report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Animal
1.2.2. Service
1.2.3. Application
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.8. List of Secondary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Animal Outlook
2.2.2. Service Outlook
2.2.3. Application Outlook
2.2.4. Regional Outlook
2.3. Competitive Insights
Chapter 3. Global Veterinary CRO and CDMO Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Global Veterinary CRO and CDMO Market Analysis Tools
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
Chapter 4. Global Veterinary CRO and CDMO Market: Animal Business Analysis
4.1. Animal Segment Dashboard
4.2. Veterinary CRO and CDMO Market: Animal Movement Analysis
4.3. Global Veterinary CRO and CDMO Market Size & Trend Analysis, By Animal, 2018 to 2030 (USD Million)
4.4. Companion Animals
4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.5. Livestock Animals
4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 5. Global Veterinary CRO and CDMO Market: Service Business Analysis
5.1. Service Segment Dashboard
5.2. Veterinary CRO and CDMO Market: Service Movement Analysis
5.3. Global Veterinary CRO and CDMO Market Size & Trend Analysis, By Service, 2018 to 2030 (USD Million)
5.4. Discovery
5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.5. Development
5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.5.2. Early Phase/Preclinical
5.5.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.5.3. Late phase/Clinical
5.5.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.6. Manufacturing
5.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.7. Packaging & Labeling
5.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.8. Market Approval & Post Marketing
5.8.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 6. Global Veterinary CRO and CDMO Market: Application Business Analysis
6.1. Application Segment Dashboard
6.2. Veterinary CRO and CDMO Market: Application Movement Analysis
6.3. Global Veterinary CRO and CDMO Market Size & Trend Analysis, By Application, 2018 to 2030 (USD Million)
6.4. Medicine
6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.4.2. Pharmaceuticals
6.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.4.3. Biologics
6.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.4.4. Others
6.4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.5. Medical Devices
6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 7. Global Veterinary CRO and CDMO Market: Regional Estimates & Trend Analysis
7.1. Regional Market Dashboard
7.2. Regional Market Share Analysis, 2024 & 2030
7.3. Global Veterinary CRO and CDMO Market by Regional: Key Takeaways
7.4. North America
7.4.1. U.S.
7.4.1.1. Key Country Dynamics
7.4.1.2. Regulatory Framework/ Reimbursement Structure
7.4.1.3. Competitive Scenario
7.4.1.4. U.S. Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.4.2. Canada
7.4.2.1. Key Country Dynamics
7.4.2.2. Regulatory Framework/ Reimbursement Structure
7.4.2.3. Competitive Scenario
7.4.2.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.4.3. Mexico
7.4.3.1. Key Country Dynamics
7.4.3.2. Regulatory Framework/ Reimbursement Structure
7.4.3.3. Competitive Scenario
7.4.3.4. Mexico Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.5. Europe
7.5.1. Germany
7.5.1.1. Key Country Dynamics
7.5.1.2. Regulatory Framework/ Reimbursement Structure
7.5.1.3. Competitive Scenario
7.5.1.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.5.2. UK
7.5.2.1. Key Country Dynamics
7.5.2.2. Regulatory Framework/ Reimbursement Structure
7.5.2.3. Competitive Scenario
7.5.2.4. UK Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.5.3. Germany
7.5.3.1. Key Country Dynamics
7.5.3.2. Regulatory Framework/ Reimbursement Structure
7.5.3.3. Competitive Scenario
7.5.3.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.5.4. France
7.5.4.1. Key Country Dynamics
7.5.4.2. Regulatory Framework/ Reimbursement Structure
7.5.4.3. Competitive Scenario
7.5.4.4. France Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.5.5. Spain
7.5.5.1. Key Country Dynamics
7.5.5.2. Regulatory Framework/ Reimbursement Structure
7.5.5.3. Competitive Scenario
7.5.5.4. Spain Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.5.6. Italy
7.5.6.1. Key Country Dynamics
7.5.6.2. Regulatory Framework/ Reimbursement Structure
7.5.6.3. Competitive Scenario
7.5.6.4. Italy Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.5.7. Denmark
7.5.7.1. Key Country Dynamics
7.5.7.2. Regulatory Framework/ Reimbursement Structure
7.5.7.3. Competitive Scenario
7.5.7.4. Denmark Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.5.8. Sweden
7.5.8.1. Key Country Dynamics
7.5.8.2. Regulatory Framework/ Reimbursement Structure
7.5.8.3. Competitive Scenario
7.5.8.4. Sweden Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.5.9. Norway
7.5.9.1. Key Country Dynamics
7.5.9.2. Regulatory Framework/ Reimbursement Structure
7.5.9.3. Competitive Scenario
7.5.9.4. Norway Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.6. Asia Pacific
7.6.1. Japan
7.6.1.1. Key Country Dynamics
7.6.1.2. Regulatory Framework/ Reimbursement Structure
7.6.1.3. Competitive Scenario
7.6.1.4. Japan Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.6.2. China
7.6.2.1. Key Country Dynamics
7.6.2.2. Regulatory Framework/ Reimbursement Structure
7.6.2.3. Competitive Scenario
7.6.2.4. China Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.6.3. India
7.6.3.1. Key Country Dynamics
7.6.3.2. Regulatory Framework/ Reimbursement Structure
7.6.3.3. Competitive Scenario
7.6.3.4. India Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.6.4. Australia
7.6.4.1. Key Country Dynamics
7.6.4.2. Regulatory Framework/ Reimbursement Structure
7.6.4.3. Competitive Scenario
7.6.4.4. Australia Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.6.5. South Korea
7.6.5.1. Key Country Dynamics
7.6.5.2. Regulatory Framework/ Reimbursement Structure
7.6.5.3. Competitive Scenario
7.6.5.4. South Korea Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.6.6. Thailand
7.6.6.1. Key Country Dynamics
7.6.6.2. Regulatory Framework/ Reimbursement Structure
7.6.6.3. Competitive Scenario
7.6.6.4. Thailand Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.7. Latin America
7.7.1. Brazil
7.7.1.1. Key Country Dynamics
7.7.1.2. Regulatory Framework/ Reimbursement Structure
7.7.1.3. Competitive Scenario
7.7.1.4. Brazil Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.7.2. Colombia
7.7.2.1. Key Country Dynamics
7.7.2.2. Regulatory Framework/ Reimbursement Structure
7.7.2.3. Competitive Scenario
7.7.2.4. Colombia Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.7.3. Argentina
7.7.3.1. Key Country Dynamics
7.7.3.2. Regulatory Framework/ Reimbursement Structure
7.7.3.3. Competitive Scenario
7.7.3.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.7.4. Chile
7.7.4.1. Key Country Dynamics
7.7.4.2. Regulatory Framework/ Reimbursement Structure
7.7.4.3. Competitive Scenario
7.7.4.4. Chile Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.8. Middle East & Africa
7.8.1. South Africa
7.8.1.1. Key Country Dynamics
7.8.1.2. Regulatory Framework/ Reimbursement Structure
7.8.1.3. Competitive Scenario
7.8.1.4. South Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.8.2. Saudi Arabia
7.8.2.1. Key Country Dynamics
7.8.2.2. Regulatory Framework/ Reimbursement Structure
7.8.2.3. Competitive Scenario
7.8.2.4. South Arabia Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.8.3. UAE
7.8.3.1. Key Country Dynamics
7.8.3.2. Regulatory Framework/ Reimbursement Structure
7.8.3.3. Competitive Scenario
7.8.3.4. UAE Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.8.4. Kuwait
7.8.4.1. Key Country Dynamics
7.8.4.2. Regulatory Framework/ Reimbursement Structure
7.8.4.3. Competitive Scenario
7.8.4.4. Kuwait Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.3.1. Key Company Heat Map Analysis, 2024
8.4. Company Profiles
8.4.1. Fortrea
8.4.1.1. Company Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. Charles River Laboratories
8.4.2.1. Company Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. Clinvet (Clinglobal)
8.4.3.1. Company Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. KLIFOVET GmbH (Argenta Group)
8.4.4.1. Company Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. OCRvet (Clinglobal)
8.4.5.1. Company Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. Knoell - Triveritas
8.4.6.1. Company Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. Veterinary Research Management
8.4.7.1. Company Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. VETSPIN SRL
8.4.8.1. Company Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. Inotiv
8.4.9.1. Company Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Strategic Initiatives
8.4.10. IDEXX
8.4.10.1. Company Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Strategic Initiatives
8.4.11. Vetio
8.4.11.1. Company Overview
8.4.11.2. Financial Performance
8.4.11.3. Product Benchmarking
8.4.11.4. Strategic Initiatives
8.4.12. TriRx Pharmaceutical Services
8.4.12.1. Company Overview
8.4.12.2. Financial Performance
8.4.12.3. Product Benchmarking
8.4.12.4. Strategic Initiatives
List of Tables
Table 1. List Of Abbreviations
Table 2. Global Veterinary CRO and CDMO Market, By Animal, 2018-2030 (USD Million)
Table 3. Global Veterinary CRO and CDMO Market, By Service, 2018-2030 (USD Million)
Table 4. Global Veterinary CRO and CDMO Market, By Application, 2018-2030 (USD Million)
Table 5. Global Veterinary CRO and CDMO Market, By Region, 2018-2030 (USD Million)
Table 6. North America Veterinary CRO and CDMO Market, By Country, 2018-2030 (USD Million)
Table 7. North America Veterinary CRO and CDMO Market, By Animal, 2018-2030 (USD Million)
Table 8. North America Veterinary CRO and CDMO Market, By Service, 2018-2030 (USD Million)
Table 9. North America Veterinary CRO and CDMO Market, By Application, 2018-2030 (USD Million)
Table 10. U.S. Veterinary CRO and CDMO Market, By Animal, 2018-2030 (USD Million)
Table 11. U.S Veterinary CRO and CDMO Market, By Service, 2018-2030 (USD Million)
Table 12. U.S. Veterinary CRO and CDMO Market, By Application, 2018-2030 (USD Million)
Table 13. Canada Veterinary CRO and CDMO Market, By Animal, 2018-2030 (USD Million)
Table 14. Canada Veterinary CRO and CDMO Market, By Service, 2018-2030 (USD Million)
Table 15. Canada Veterinary CRO and CDMO Market, By Application, 2018-2030 (USD Million)
Table 16. Mexico Veterinary CRO and CDMO Market, By Animal, 2018-2030 (USD Million)
Table 17. Mexico Veterinary CRO and CDMO Market, By Service, 2018-2030 (USD Million)
Table 18. Mexico Veterinary CRO and CDMO Market, By Application, 2018-2030 (USD Million)
Table 19. Europe Veterinary CRO and CDMO Market, By Country, 2018-2030 (USD Million)
Table 20. Europe Veterinary CRO and CDMO Market, By Animal, 2018-2030 (USD Million)
Table 21. Europe Veterinary CRO and CDMO Market, By Service, 2018-2030 (USD Million)
Table 22. Europe Veterinary CRO and CDMO Market, By Application, 2018-2030 (USD Million)
Table 23. Germany Veterinary CRO and CDMO Market, By Animal, 2018-2030 (USD Million)
Table 24. Germany Veterinary CRO and CDMO Market, By Service, 2018-2030 (USD Million)
Table 25. Germany Veterinary CRO and CDMO Market, By Application, 2018-2030 (USD Million)
Table 26. UK Veterinary CRO and CDMO Market, By Animal, 2018-2030 (USD Million)
Table 27. UK Veterinary CRO and CDMO Market, By Service, 2018-2030 (USD Million)
Table 28. UK Veterinary CRO and CDMO Market, By Application, 2018-2030 (USD Million)
Table 29. France Veterinary CRO and CDMO Market, By Animal, 2018-2030 (USD Million)
Table 30. France Veterinary CRO and CDMO Market, By Service, 2018-2030 (USD Million)
Table 31. France Veterinary CRO and CDMO Market, By Application, 2018-2030 (USD Million)
Table 32. Italy Veterinary CRO and CDMO Market, By Animal, 2018-2030 (USD Million)
Table 33. Italy Veterinary CRO and CDMO Market, By Service, 2018-2030 (USD Million)
Table 34. Italy Veterinary CRO and CDMO Market, By Application, 2018-2030 (USD Million)
Table 35. Spain Veterinary CRO and CDMO Market, By Animal, 2018-2030 (USD Million)
Table 36. Spain Veterinary CRO and CDMO Market, By Service, 2018-2030 (USD Million)
Table 37. Spain Veterinary CRO and CDMO Market, By Application, 2018-2030 (USD Million)
Table 38. Denmark Veterinary CRO and CDMO Market, By Animal, 2018-2030 (USD Million)
Table 39. Denmark Veterinary CRO and CDMO Market, By Service, 2018-2030 (USD Million)
Table 40. Denmark Veterinary CRO and CDMO Market, By Application, 2018-2030 (USD Million)
Table 41. Sweden Veterinary CRO and CDMO Market, By Animal, 2018-2030 (USD Million)
Table 42. Sweden Veterinary CRO and CDMO Market, By Service, 2018-2030 (USD Million)
Table 43. Sweden Veterinary CRO and CDMO Market, By Application, 2018-2030 (USD Million)
Table 44. Norway Veterinary CRO and CDMO Market, By Animal, 2018-2030 (USD Million)
Table 45. Norway Veterinary CRO and CDMO Market, By Service, 2018-2030 (USD Million)
Table 46. Norway Veterinary CRO and CDMO Market, By Application, 2018-2030 (USD Million)
Table 47. Asia Pacific Veterinary CRO and CDMO Market, By Country, 2018-2030 (USD Million)
Table 48. Asia Pacific Veterinary CRO and CDMO Market, By Animal, 2018-2030 (USD Million)
Table 49. Asia Pacific Veterinary CRO and CDMO Market, By Service, 2018-2030 (USD Million)
Table 50. Asia Pacific Veterinary CRO and CDMO Market, By Application, 2018-2030 (USD Million)
Table 51. China Veterinary CRO and CDMO Market, By Animal, 2018-2030 (USD Million)
Table 52. China Veterinary CRO and CDMO Market, By Service, 2018-2030 (USD Million)
Table 53. China Veterinary CRO and CDMO Market, By Application, 2018-2030 (USD Million)
Table 54. Japan Veterinary CRO and CDMO Market, By Animal, 2018-2030 (USD Million)
Table 55. Japan Veterinary CRO and CDMO Market, By Service, 2018-2030 (USD Million)
Table 56. Japan Veterinary CRO and CDMO Market, By Application, 2018-2030 (USD Million)
Table 57. India Veterinary CRO and CDMO Market, By Animal, 2018-2030 (USD Million)
Table 58. India Veterinary CRO and CDMO Market, By Service, 2018-2030 (USD Million)
Table 59. India Veterinary CRO and CDMO Market, By Application, 2018-2030 (USD Million)
Table 60. Australia Veterinary CRO and CDMO Market, By Animal, 2018-2030 (USD Million)
Table 61. Australia Veterinary CRO and CDMO Market, By Service, 2018-2030 (USD Million)
Table 62. Australia Veterinary CRO and CDMO Market, By Application, 2018-2030 (USD Million)
Table 63. South Korea Veterinary CRO and CDMO Market, By Animal, 2018-2030 (USD Million)
Table 64. South Korea Veterinary CRO and CDMO Market, By Service, 2018-2030 (USD Million)
Table 65. South Korea Veterinary CRO and CDMO Market, By Application, 2018-2030 (USD Million)
Table 66. Thailand Veterinary CRO and CDMO Market, By Animal, 2018-2030 (USD Million)
Table 67. Thailand Veterinary CRO and CDMO Market, By Service, 2018-2030 (USD Million)
Table 68. Thailand Veterinary CRO and CDMO Market, By Application, 2018-2030 (USD Million)
Table 69. Latin America Veterinary CRO and CDMO Market, By Country, 2018-2030 (USD Million)
Table 70. Latin America Veterinary CRO and CDMO Market, By Animal, 2018-2030 (USD Million)
Table 71. Latin America Veterinary CRO and CDMO Market, By Service, 2018-2030 (USD Million)
Table 72. Latin America Veterinary CRO and CDMO Market, By Application, 2018-2030 (USD Million)
Table 73. Brazil Veterinary CRO and CDMO Market, By Animal, 2018-2030 (USD Million)
Table 74. Brazil Veterinary CRO and CDMO Market, By Service, 2018-2030 (USD Million)
Table 75. Brazil Veterinary CRO and CDMO Market, By Application, 2018-2030 (USD Million)
Table 76. Columbia Veterinary CRO and CDMO Market, By Animal, 2018-2030 (USD Million)
Table 77. Columbia Veterinary CRO and CDMO Market, By Service, 2018-2030 (USD Million)
Table 78. Columbia Veterinary CRO and CDMO Market, By Application, 2018-2030 (USD Million)
Table 79. Argentina Veterinary CRO and CDMO Market, By Animal, 2018-2030 (USD Million)
Table 80. Argentina Veterinary CRO and CDMO Market, By Service, 2018-2030 (USD Million)
Table 81. Argentina Veterinary CRO and CDMO Market, By Application, 2018-2030 (USD Million)
Table 82. Chile Veterinary CRO and CDMO Market, By Animal, 2018-2030 (USD Million)
Table 83. Chile Veterinary CRO and CDMO Market, By Service, 2018-2030 (USD Million)
Table 84. Chile Veterinary CRO and CDMO Market, By Application, 2018-2030 (USD Million)
Table 85. MEA Veterinary CRO and CDMO Market, By Region, 2018-2030 (USD Million)
Table 86. MEA Veterinary CRO and CDMO Market, By Animal, 2018-2030 (USD Million)
Table 87. MEA Veterinary CRO and CDMO Market, By Service, 2018-2030 (USD Million)
Table 88. MEA Veterinary CRO and CDMO Market, By Application, 2018-2030 (USD Million)
Table 89. South Africa Veterinary CRO and CDMO Market, By Animal, 2018-2030 (USD Million)
Table 90. South Africa Veterinary CRO and CDMO Market, By Service, 2018-2030 (USD Million)
Table 91. South Africa Veterinary CRO and CDMO Market, By Application, 2018-2030 (USD Million)
Table 92. Saudi Arabia Veterinary CRO and CDMO Market, By Animal, 2018-2030 (USD Million)
Table 93. Saudi Arabia Veterinary CRO and CDMO Market, By Service, 2018-2030 (USD Million)
Table 94. Saudi Arabia Veterinary CRO and CDMO Market, By Application, 2018-2030 (USD Million)
Table 95. UAE Veterinary CRO and CDMO Market, By Animal, 2018-2030 (USD Million)
Table 96. UAE Veterinary CRO and CDMO Market, By Service, 2018-2030 (USD Million)
Table 97. UAE Veterinary CRO and CDMO Market, By Application, 2018-2030 (USD Million)
Table 98. Kuwait Veterinary CRO and CDMO Market, By Animal, 2018-2030 (USD Million)
Table 99. Kuwait Veterinary CRO and CDMO Market, By Service, 2018-2030 (USD Million)
Table 100 Kuwait Veterinary CRO and CDMO Market, By Application, 2018-2030 (USD Million)
List of Figures
Figure 1 Market Research Process
Figure 2 Data Triangulation Techniques
Figure 3 Primary Research Pattern
Figure 4 Primary Interviews
Figure 5 Market Research Approaches
Figure 6 Value-Chain-Based Sizing & Forecasting
Figure 7 QFD Modeling for Market Share Assessment
Figure 8 Market Formulation & Validation
Figure 9 Veterinary CRO and CDMO Market: Market Outlook
Figure 10 Veterinary CRO and CDMO Competitive Insights
Figure 11 Parent Market Outlook
Figure 12 Related/Ancillary Market Outlook
Figure 13 Penetration and Growth Prospect Mapping
Figure 14 Industry Value Chain Analysis
Figure 15 Veterinary CRO and CDMO Market Driver Impact
Figure 16 Veterinary CRO and CDMO Market Restraint Impact
Figure 17 Veterinary CRO and CDMO Market Strategic Initiatives Analysis
Figure 18 Veterinary CRO and CDMO Market: Animal Movement Analysis
Figure 19 Veterinary CRO and CDMO Market: Animal Outlook and Key Takeaways
Figure 20 Companion Animal Market Estimates and Forecast, 2018-2030
Figure 21 Livestock Animal Market Estimates and Forecast, 2018-2030
Figure 22 Veterinary CRO and CDMO Market: Service Movement Analysis
Figure 23 Veterinary CRO and CDMO Market: Service Outlook and Key Takeaway
Figure 24 Discovery Market Estimates and Forecast, 2018-2030
Figure 25 Development Market Estimates and Forecast, 2018-2030
Figure 26 Early Phase/Preclinical Development Market Estimates and Forecast, 2018-2030
Figure 27 Late phase/Clinical Development Market Estimates and Forecast, 2018-2030
Figure 28 Manufacturing Market Estimates and Forecast, 2018-2030
Figure 29 Packaging & Labeling Market Estimates and Forecast, 2018-2030
Figure 30 Market Approval & Post Marketing Market Estimates and Forecast, 2018-2030
Figure 31 Veterinary CRO and CDMO Market: Application Movement Analysis
Figure 32 Veterinary CRO and CDMO Market: Application Outlook and Key Takeaways
Figure 33 Medicine Market Estimates and Forecast, 2018-2030
Figure 34 Pharmaceuticals Market Estimates and Forecast, 2018-2030
Figure 35 Biologics Market Estimates and Forecast, 2018-2030
Figure 36 Others Market Estimates and Forecast, 2018-2030
Figure 37 Medical Devices Market Estimates and Forecast, 2018-2030
Figure 38 Global Veterinary CRO and CDMO Market: Regional Movement Analysis
Figure 39 Global Veterinary CRO and CDMO Market: Regional Outlook and Key Takeaways
Figure 40 North America Market Estimates and Forecasts, 2018-2030
Figure 41 U.S. Market Estimates and Forecasts, 2018-2030
Figure 42 Canada Market Estimates and Forecasts, 2018-2030
Figure 43 Mexico Market Estimates and Forecasts, 2018-2030
Figure 44 Europe Market Estimates and Forecasts, 2018-2030
Figure 45 UK Market Estimates and Forecasts, 2018-2030
Figure 46 Germany Market Estimates and Forecasts, 2018-2030
Figure 47 France Market Estimates and Forecasts, 2018-2030
Figure 48 Italy Market Estimates and Forecasts, 2018-2030
Figure 49 Spain Market Estimates and Forecasts, 2018-2030
Figure 50 Denmark Market Estimates and Forecasts, 2018-203
Figure 51 Sweden Market Estimates and Forecasts, 2018-203
Figure 52 Norway Market Estimates and Forecasts, 2018-203
Figure 53 Asia Pacific Market Estimates and Forecasts, 2018-2030
Figure 54 China Market Estimates and Forecasts, 2018-2030
Figure 55 Japan Market Estimates and Forecasts, 2018-2030
Figure 56 India Market Estimates and Forecasts, 2018-2030
Figure 57 Australia Market Estimates and Forecasts, 2018-2030
Figure 58 South Korea Market Estimates and Forecasts, 2018-2030
Figure 59 Thailand Market Estimates and Forecasts, 2018-2030
Figure 60 Latin America Market Estimates and Forecasts, 2018-2030
Figure 61 Brazil Market Estimates and Forecasts, 2018-2030
Figure 62 Columbia Market Estimates and Forecasts, 2018-2030
Figure 63 Argentina Market Estimates and Forecasts, 2018-2030
Figure 64 Chile Market Estimates and Forecasts, 2018-2030
Figure 65 Middle East and Africa Market Estimates and Forecasts, 2018-2030
Figure 66 South Africa Market Estimates and Forecasts, 2018-2030
Figure 67 Saudi Arabia Market Estimates and Forecasts, 2018-2030
Figure 68 UAE Market Estimates and Forecasts, 2018-2030
Figure 69 Kuwait Market Estimates and Forecasts, 2018-2030

Companies Mentioned

The major companies featured in this Veterinary CRO and CDMO market report include:
  • Fortrea
  • Charles River Laboratories
  • Clinvet (Clinglobal)
  • KLIFOVET GmbH (Argenta Group)
  • OCRvet (Clinglobal)
  • Knoell - Triveritas
  • Veterinary Research Management
  • VETSPIN SRL
  • Inotiv
  • IDEXX
  • Vetio
  • TriRx Pharmaceutical Services

Table Information